| Jennifer Black, PA-C | |
|
583 S Clarizz Blvd, Bloomington, IN 47401-5515 | |
| (812) 333-2663 | |
| Not Available |
| Full Name | Jennifer Black |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 15 Years |
| Location | 583 S Clarizz Blvd, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316173727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 10001094A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health Bloomington Hospital | Bloomington, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Southern Indiana Physicians Llc | 6204748197 | 449 |
News Archive
The world's most widespread test for ovarian cancer reports false-positives in 94 of 100 diagnosed cases. Now, chemists at the University of Copenhagen working with clinical researchers at University College London have developed a method able to halve the number of false-positives. When fully developed, the new test will spare a significant number of women from unnecessary worry and further testing. Furthermore, global health care providers stand to save substantial sums - just by including a test on a certain sugar molecule in tandem with the currently prevailing diagnostic test.
Pregnant women had a disproportionately higher risk of death due to 2009 influenza A(H1N1) in the U.S., and early antiviral treatment appeared to be associated with fewer admissions to an ICU and fewer deaths, according to a study in the April 21 issue of JAMA.
Investigators developing an inhalable nanoparticle for treating lung cancer have shown that a surface molecule found on malignant lung cells can serve as an effective target for improving drug delivery.
About 33 percent of people with type 2 diabetes suffer kidney damage that progresses to end stage renal disease, at which point they require either dialysis or kidney transplantation. Scientists have thought that this kidney disease is driven by damage to the glomeruli, blood vessels in the kidney, which spill the protein albumin into the urine. Current treatments targeting the resulting "albuminuria" do not prevent kidney failure.
Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of healthcare supplies, announced today the signing of a cost management prime vendor agreement with Bloomington Hospital in Bloomington, Ind. The five-year agreement is anticipated to save the hospital an estimated $2 million over the term of the contract.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Black, PA-C 583 S Clarizz Blvd, Bloomington, IN 47401-5515 Ph: () - | Jennifer Black, PA-C 583 S Clarizz Blvd, Bloomington, IN 47401-5515 Ph: (812) 333-2663 |
News Archive
The world's most widespread test for ovarian cancer reports false-positives in 94 of 100 diagnosed cases. Now, chemists at the University of Copenhagen working with clinical researchers at University College London have developed a method able to halve the number of false-positives. When fully developed, the new test will spare a significant number of women from unnecessary worry and further testing. Furthermore, global health care providers stand to save substantial sums - just by including a test on a certain sugar molecule in tandem with the currently prevailing diagnostic test.
Pregnant women had a disproportionately higher risk of death due to 2009 influenza A(H1N1) in the U.S., and early antiviral treatment appeared to be associated with fewer admissions to an ICU and fewer deaths, according to a study in the April 21 issue of JAMA.
Investigators developing an inhalable nanoparticle for treating lung cancer have shown that a surface molecule found on malignant lung cells can serve as an effective target for improving drug delivery.
About 33 percent of people with type 2 diabetes suffer kidney damage that progresses to end stage renal disease, at which point they require either dialysis or kidney transplantation. Scientists have thought that this kidney disease is driven by damage to the glomeruli, blood vessels in the kidney, which spill the protein albumin into the urine. Current treatments targeting the resulting "albuminuria" do not prevent kidney failure.
Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of healthcare supplies, announced today the signing of a cost management prime vendor agreement with Bloomington Hospital in Bloomington, Ind. The five-year agreement is anticipated to save the hospital an estimated $2 million over the term of the contract.
› Verified 8 days ago
Mr. Steven Meeks, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 415 S Landmark Ave, Bloomington, IN 47403 Phone: 812-558-0612 Fax: 812-333-7435 | |
William L Latimer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2605 E Creeks Edge Dr, Bloomington, IN 47401 Phone: 812-355-2300 | |
Mr. Scott John Hopkins, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2605 E Creeks Edge Dr, Bloomington, IN 47401 Phone: 812-355-2300 Fax: 812-355-2317 | |
Miss Cheyenne Olivia Powers, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 813 W 2nd St, Bloomington, IN 47403 Phone: 812-330-0303 | |
Riddhi Gandhi, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 601 W 2nd St, Bloomington, IN 47403 Phone: 812-353-9515 | |
Mr. Steven Eugene Jacobs, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 600 N Jordan Ave, Bloomington, IN 47405 Phone: 812-855-1272 | |
Stephanie M West, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1520 S Liberty Dr, Bloomington, IN 47403 Phone: 812-676-4300 Fax: 812-339-8399 |